Locking the Door to Leukocytes: Use of Integrin Inhibitors for the Treatment of Crohn’s Disease
Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s4013
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2010
Authors
Publisher
SAGE Publications